# Hefei Tuosheng Pharmaceutical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hefei-tuosheng-pharmaceutical-technology-co

- Industry: Biotechnology
- Headquarters: Hefei, China
- Latest round: Angel (Dec 10, 2025)
- Investors on record: 5

## About

Based in Hefei, China and founded in 2025, Hefei Tuosheng Pharmaceutical Technology Co., Ltd. is a biopharmaceutical company operating in the field of innovative oncology therapies. In January 2026, Hefei Tuosheng Pharmaceutical Technology Co., Ltd. closed Pre-A funding from new investors Feixi Urban and Rural Construction Investment and Hainan New Haofei.

Hefei Tuosheng Pharmaceutical Technology Co., Ltd. primarily focuses on the research and development of third-generation antibody-drug conjugates (ADCs), concentrating on innovative research and development design of multi-target and differentiated payloads and oncology pipeline development.

The company generates revenue from developing antibody-drug conjugates and other biopharmaceutical products.

## Funding rounds

- Angel, Dec 10, 2025 — Hefei State-Owned Assets Holding, Beijia Investment Management, Jiliuling Capital
- Angel, Nov 25, 2025 — Jiadao Private Capital, Together To Miracle

## Investors

- Jiadao Private Capital — Angel
- Together To Miracle — Angel
- Hefei State-Owned Assets Holding (https://capitalatlas.ai/funds/hefei-state-owned-assets-holding) — Angel
- Beijia Investment Management (https://capitalatlas.ai/funds/beijia-investment-management) — Angel
- Jiliuling Capital (https://capitalatlas.ai/funds/jiliuling-capital) — Angel